Chemoradiation is the major treatment option in unresectable, locally advanced non-small
cell lung cancer. Many clinical trials have evaluated the efficacy of different combinations of …

非小细胞肺癌(non. small cell lung cancer, NSCLC) 占肺癌的70% 一80%, 放化疗联合治疗
NSCLC 能提高局部控制率和长期生存率. 多西他赛作为新型抗肿瘤药物, 对NSCLC …

The North Central Cancer Treatment Group (NCCTG) was founded in 1977 as a regional
cooperative group to allow cancer patients in the upper Midwest of the United States to gain …

Purpose To evaluate the outcome of radiotherapy (RT) versus radiochemotherapy (RT-CHT)
in patients with locally advanced (stage III) inoperable adenocarcinoma of the lung. Patients …

Представлена сравнительная оценка химиолучевого лечения в режиме ускоренного
гиперфракционирования с неравномерным дроблением дневной дозы с …

• Post-RT, there are multiple biochemical and molecular events involving type II
pneumocytes, surfactant protein transudation into alveolar spaces, with subsequent …

Lung cancer is a disease of older persons. It is the most common cause of cancer death in
men and women in the United States. A comprehensive evaluation of medical comorbidities …

The present chapter presents the different treatment approaches for locally advanced non
small cell lung cancer including radiation alone, targeted agents, combining chemotherapy …

Résumé La chimioradiothérapie est l'une des thérapeutiques majeures en oncologie
thoracique: aux côtés de la chirurgie, traitement des tumeurs bronchiques d'extension …